ALK inhibitor

Results: 36



#Item
21Instructions for Use  Archer™ FusionPlex™ ALK, RET, ROS1 Panel v2 AK0028-8  Description

Instructions for Use Archer™ FusionPlex™ ALK, RET, ROS1 Panel v2 AK0028-8 Description

Add to Reading List

Source URL: archerdx.com

Language: English - Date: 2015-02-19 18:39:00
22Microsoft Word[removed]ALK-Final DAP.docx

Microsoft Word[removed]ALK-Final DAP.docx

Add to Reading List

Source URL: www.msac.gov.au

Language: English - Date: 2015-03-20 01:49:46
23Microsoft Word[removed]ALK-Final DAP.docx

Microsoft Word[removed]ALK-Final DAP.docx

Add to Reading List

Source URL: www.msac.gov.au

Language: English - Date: 2014-11-06 23:49:15
24Microsoft Word[removed]PSD - ALK testing for crizotinib-accessible.DOCX

Microsoft Word[removed]PSD - ALK testing for crizotinib-accessible.DOCX

Add to Reading List

Source URL: www.msac.gov.au

Language: English - Date: 2014-12-03 00:24:13
25ALK rearrangement found in nearly 10 percent of patients in Lung Cancer Mutation Consortium

ALK rearrangement found in nearly 10 percent of patients in Lung Cancer Mutation Consortium

Add to Reading List

Source URL: medicalxpress.com

Language: English - Date: 2015-02-26 07:56:12
26Lung Cancer, EGFR with ALK reflex, Tumor Algorithm  Clinical diagnosis of non-small-cell lung cancer. Order: EGFRX / Lung Cancer, EGFR with ALK reflex, Tumor

Lung Cancer, EGFR with ALK reflex, Tumor Algorithm Clinical diagnosis of non-small-cell lung cancer. Order: EGFRX / Lung Cancer, EGFR with ALK reflex, Tumor

Add to Reading List

Source URL: www.mayomedicallaboratories.com

Language: English - Date: 2014-08-08 15:15:55
27GANETESPIB  BACKGROUND INFORMATION FOR THE PEDIATRIC SUBCOMMITTEE MEETING OF THE ONCOLOGIC DRUGS ADVISORY COMMITTEE

GANETESPIB BACKGROUND INFORMATION FOR THE PEDIATRIC SUBCOMMITTEE MEETING OF THE ONCOLOGIC DRUGS ADVISORY COMMITTEE

Add to Reading List

Source URL: www.fda.gov

Language: English
28Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Summary of Recommendations Section I. When Should Molecular Testing of Lung Cancers Be Performed? Question 1.

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Summary of Recommendations Section I. When Should Molecular Testing of Lung Cancers Be Performed? Question 1.

Add to Reading List

Source URL: www.amp.org

Language: English - Date: 2013-04-03 10:57:43
29Microsoft PowerPoint - Garraway.pptx

Microsoft PowerPoint - Garraway.pptx

Add to Reading List

Source URL: deainfo.nci.nih.gov

Language: English - Date: 2014-02-26 09:53:42
30Press Release  September 10, 2012 Announcement of the Keio Medical Science Prize 2012 Keio University annually awards the Keio Medical Science Prize to recognize researchers who have

Press Release September 10, 2012 Announcement of the Keio Medical Science Prize 2012 Keio University annually awards the Keio Medical Science Prize to recognize researchers who have

Add to Reading List

Source URL: www.keio.ac.jp

Language: English - Date: 2013-02-24 23:17:46